{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:37:09Z","timestamp":1781023029517,"version":"3.54.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["CSUR240320210052"],"award-info":[{"award-number":["CSUR240320210052"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"DOI":"10.1186\/s13643-026-03117-w","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T03:33:57Z","timestamp":1771040037000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of diabetic cardiomyopathy in low- and middle-income countries: a systematic review protocol"],"prefix":"10.1186","volume":"15","author":[{"given":"A.","family":"Arowolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. D. M.","family":"Bennie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Werfalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. E.","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"key":"3117_CR1","unstructured":"IDF. Facts & figures. 2025. Available from: https:\/\/idf.org\/about-diabetes\/diabetes-facts-figures\/. Cited 2026 23 January."},{"key":"3117_CR2","unstructured":"IDF. Global - diabetes global report 2000 \u2014 2050. 2026. Available from: https:\/\/diabetesatlas.org\/data-by-location\/global\/. Cited 2026 23 January."},{"key":"3117_CR3","unstructured":"WHO. Diabetes. 2024. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes. Cited 2026 23 January.\u00a0"},{"issue":"2","key":"3117_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S2213-8587(25)00299-2","volume":"14","author":"I Genitsaridi","year":"2026","unstructured":"Genitsaridi I, et al. Of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050. Lancet Diabetes Endocrinol. 2026;14(2):149\u201356.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"3117_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.71376","volume":"8","author":"MSH Rafi","year":"2025","unstructured":"Rafi MSH, Ivy SC, Dewan SMR. A review on the double burden of diabetes and myocardial infarction: healthcare challenges and future prospects in low and middle-income countries. Health Sci Rep. 2025;8(10):e71376.","journal-title":"Health Sci Rep"},{"key":"3117_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1 Suppl 1","key":"3117_CR7","first-page":"e1","volume":"25","author":"N Marx","year":"2024","unstructured":"Marx N, et al. 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. G Ital Cardiol (Rome). 2024;25(1 Suppl 1):e1\u2013103.","journal-title":"G Ital Cardiol (Rome)"},{"key":"3117_CR8","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.11.04040","volume":"11","author":"AA Lam","year":"2021","unstructured":"Lam AA, et al. Diabetes comorbidities in low-and middle-income countries: an umbrella review. J Glob Health. 2021;11:04040.","journal-title":"J Glob Health"},{"issue":"12","key":"3117_CR9","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2512436","volume":"25","author":"NH Siam","year":"2024","unstructured":"Siam NH, et al. Diabetes mellitus and cardiovascular disease: exploring epidemiology, pathophysiology, and treatment strategies. Rev Cardiovasc Med. 2024;25(12):436.","journal-title":"Rev Cardiovasc Med"},{"issue":"1","key":"3117_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12933-022-01516-6","volume":"21","author":"C-X Ma","year":"2022","unstructured":"Ma C-X, et al. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovasc Diabetol. 2022;21(1):74.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3117_CR11","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1186\/s12889-025-22702-7","volume":"25","author":"X-Y Zhu","year":"2025","unstructured":"Zhu X-Y, et al. Global, regional, and national burden of cardiovascular diseases attributable to metabolic risks across all age groups from 1990 to 2021: an analysis of the 2021 global burden of disease study data. BMC Public Health. 2025;25(1):1704.","journal-title":"BMC Public Health"},{"issue":"18","key":"3117_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14186678","volume":"14","author":"A Caturano","year":"2025","unstructured":"Caturano A, et al. Rethinking the diabetes\u2013cardiovascular disease continuum: toward integrated care. J Clin Med. 2025;14(18):6678.","journal-title":"J Clin Med"},{"issue":"3","key":"3117_CR13","doi-asserted-by":"publisher","first-page":"464","DOI":"10.2337\/dc24-0654","volume":"48","author":"AD Kaze","year":"2025","unstructured":"Kaze AD, et al. Diabetes, subclinical myocardial injury or stress, and risk of heart failure subtypes: the Jackson Heart Study. Diabetes Care. 2025;48(3):464\u201372.","journal-title":"Diabetes Care"},{"key":"3117_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1630686","volume":"16","author":"X Chen","year":"2025","unstructured":"Chen X, et al. Type 2 diabetes mediated heart failure: focus on early recognition and clinical strategies. Front Endocrinol (Lausanne). 2025;16:1630686.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"3117_CR15","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.2337\/dci22-0014","volume":"45","author":"R Pop-Busui","year":"2022","unstructured":"Pop-Busui R, et al. Heart failure: an underappreciated complication of diabetes. A consensus report of the American Diabetes Association. Diabetes Care. 2022;45(7):1670\u201390.","journal-title":"Diabetes Care"},{"key":"3117_CR16","doi-asserted-by":"publisher","DOI":"10.2337\/db23-1231-P","author":"J Echouffo Tcheugui","year":"2023","unstructured":"Echouffo Tcheugui J, et al. 1231-P: influence of diabetes on the progression of preclinical stage B heart failure phenotypes to heart failure. Diabetes. 2023. https:\/\/doi.org\/10.2337\/db23-1231-P.","journal-title":"Diabetes"},{"issue":"5","key":"3117_CR17","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.numecd.2023.12.013","volume":"34","author":"K Matsushita","year":"2024","unstructured":"Matsushita K, et al. Prevalence and clinical characteristics of diabetic cardiomyopathy in patients with acute heart failure. Nutr Metab Cardiovasc Dis. 2024;34(5):1325\u201333.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"3117_CR18","first-page":"18","volume":"30","author":"SL Xiao","year":"2023","unstructured":"Xiao SL, et al. Diabetic cardiomyopathy: an educational review. Br J Cardiol. 2023;30(2):18.","journal-title":"Br J Cardiol"},{"issue":"5","key":"3117_CR19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2337\/dbi23-0019","volume":"73","author":"LC Heather","year":"2024","unstructured":"Heather LC, et al. Redefining diabetic cardiomyopathy: perturbations in substrate metabolism at the heart of its pathology. Diabetes. 2024;73(5):659\u201370.","journal-title":"Diabetes"},{"issue":"8","key":"3117_CR20","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/CIRCRESAHA.118.314665","volume":"124","author":"WH Dillmann","year":"2019","unstructured":"Dillmann WH. Diabetic cardiomyopathy: what is it and can it be fixed? Circ Res. 2019;124(8):1160\u20132.","journal-title":"Circ Res"},{"key":"3117_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1451100","volume":"15","author":"P Galis","year":"2024","unstructured":"Galis P, et al. Update on clinical and experimental management of diabetic cardiomyopathy: addressing current and future therapy. Front Endocrinol. 2024;15:1451100.","journal-title":"Front Endocrinol"},{"issue":"4","key":"3117_CR22","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3390\/medicina61040567","volume":"61","author":"L D\u0103niluc","year":"2025","unstructured":"D\u0103niluc L, et al. Subclinical changes in type 2 diabetes patients with heart failure stage A and B treated with oral semaglutide. Medicina (Kaunas). 2025;61(4):567.","journal-title":"Medicina (Kaunas)"},{"key":"3117_CR23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ijcard.2016.07.083","volume":"221","author":"PG J\u00f8rgensen","year":"2016","unstructured":"J\u00f8rgensen PG, et al. Impact of type 2 diabetes and duration of type 2 diabetes on cardiac structure and function. Int J Cardiol. 2016;221:114\u201321.","journal-title":"Int J Cardiol"},{"issue":"5","key":"3117_CR24","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s12265-010-9197-3","volume":"3","author":"S Singh","year":"2010","unstructured":"Singh S, et al. Risk factors preceding type 2 diabetes and cardiomyopathy. J Cardiovasc Transl Res. 2010;3(5):580\u201396.","journal-title":"J Cardiovasc Transl Res"},{"issue":"23","key":"3117_CR25","doi-asserted-by":"publisher","first-page":"e535","DOI":"10.1161\/CIR.0000000000000450","volume":"134","author":"B Bozkurt","year":"2016","unstructured":"Bozkurt B, et al. Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association. Circulation. 2016;134(23):e535\u201378.","journal-title":"Circulation"},{"key":"3117_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2022.100126","volume":"3","author":"U Sharma","year":"2022","unstructured":"Sharma U, et al. Cellular and molecular mechanisms, genetic predisposition and treatment of diabetes-induced cardiomyopathy. Current Research in Pharmacology and Drug Discovery. 2022;3:100126.","journal-title":"Current Research in Pharmacology and Drug Discovery"},{"key":"3117_CR27","doi-asserted-by":"crossref","unstructured":"Ajele KW, Ugwu LE, Idemudia ES. Diabetes in Africa: rising prevalence, premature death, and health system challenges, 2024\u20132050. Premature Death, and Health System Challenges, 2024;2050.","DOI":"10.2139\/ssrn.5602710"},{"issue":"1","key":"3117_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2174\/1573399819666230413094200","volume":"20","author":"A Kumar","year":"2024","unstructured":"Kumar A, et al. Prevalence of diabetes in India: a review of IDF diabetes atlas 10th edition. Curr Diabetes Rev. 2024;20(1):105\u201314.","journal-title":"Curr Diabetes Rev"},{"issue":"1","key":"3117_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12916-024-03401-3","volume":"22","author":"I Swiatkiewicz","year":"2024","unstructured":"Swiatkiewicz I, et al. Prevalence of diabetic cardiomyopathy in patients with type 2 diabetes in a large academic medical center. BMC Med. 2024;22(1):195.","journal-title":"BMC Med"},{"issue":"16","key":"3117_CR30","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.jacc.2021.08.020","volume":"78","author":"MW Segar","year":"2021","unstructured":"Segar MW, et al. Prevalence and prognostic implications of diabetes with cardiomyopathy in community-dwelling adults. J Am Coll Cardiol. 2021;78(16):1587\u201398.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"3117_CR31","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1177\/19322968231212219","volume":"19","author":"A Nagori","year":"2025","unstructured":"Nagori A, et al. Prevalence and predictors of subclinical cardiomyopathy in patients with type 2 diabetes in a health system. J Diabetes Sci Technol. 2025;19(3):699\u2013704.","journal-title":"J Diabetes Sci Technol"},{"key":"3117_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1380809","volume":"11","author":"S Mendis","year":"2024","unstructured":"Mendis S, Graham I. Prevention and control of cardiovascular disease in \u201creal-world\u201d settings: sustainable implementation of effective policies. Front Cardiovasc Med. 2024;11:1380809.","journal-title":"Front Cardiovasc Med"},{"issue":"7","key":"3117_CR33","doi-asserted-by":"publisher","first-page":"e665","DOI":"10.1016\/S2214-109X(17)30196-1","volume":"5","author":"H Dokainish","year":"2017","unstructured":"Dokainish H, et al. Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study. Lancet Glob Health. 2017;5(7):e665\u201372.","journal-title":"Lancet Glob Health"},{"key":"3117_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"3117_CR35","doi-asserted-by":"crossref","unstructured":"Tugwell P, Tovey D. PRISMA 2020.\u00a0J Clin Epidemiol. 2021;134:A5-6.","DOI":"10.1016\/j.jclinepi.2021.04.008"},{"key":"3117_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1\u20139.","journal-title":"Syst Rev"},{"issue":"3","key":"3117_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","volume":"13","author":"Z Munn","year":"2015","unstructured":"Munn Z, et al. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc. 2015;13(3):147\u201353.","journal-title":"Int J Evid Based Healthc"},{"key":"3117_CR38","first-page":"117","volume-title":"JBI manual for evidence synthesis","author":"Z Munn","year":"2020","unstructured":"Munn Z. Systematic reviews of prevalence and incidence. In: JBI manual for evidence synthesis. JBI Adelaide, Australia; 2020. p. 117\u2013217."},{"issue":"1","key":"3117_CR39","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1210\/clinem\/dgad482","volume":"109","author":"TA Hitt","year":"2024","unstructured":"Hitt TA, Hannon TS, Magge SN. Approach to the patient: youth-onset type 2 diabetes. J Clin Endocrinol Metab. 2024;109(1):245\u201355.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"3117_CR40","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41581-022-00645-1","volume":"19","author":"P Bjornstad","year":"2023","unstructured":"Bjornstad P, et al. Youth-onset type 2 diabetes mellitus: an urgent challenge. Nat Rev Nephrol. 2023;19(3):168\u201384.","journal-title":"Nat Rev Nephrol"},{"key":"3117_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-017-0506-x","volume":"16","author":"A Lorenzo-Almor\u00f3s","year":"2017","unstructured":"Lorenzo-Almor\u00f3s A, et al. Diagnostic approaches for diabetic cardiomyopathy. Cardiovasc Diabetol. 2017;16:1\u201314.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"3117_CR42","doi-asserted-by":"publisher","first-page":"e294","DOI":"10.1161\/CIR.0000000000000691","volume":"140","author":"SM Dunlay","year":"2019","unstructured":"Dunlay SM, et al. Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not represent an update of the 2017 ACC\/AHA\/HFSA heart failure guideline update. Circulation. 2019;140(7):e294\u2013324.","journal-title":"Circulation"},{"issue":"1","key":"3117_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1-39.e14.","journal-title":"J Am Soc Echocardiogr"},{"issue":"4","key":"3117_CR44","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus WJ, Tsch\u00f6pe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62(4):263\u201371.","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 3","key":"3117_CR45","doi-asserted-by":"publisher","first-page":"A73","DOI":"10.1136\/heartjnl-2014-306118.127","volume":"100","author":"E Levelt","year":"2014","unstructured":"Levelt E, et al. 127 early manifestations of diabetic cardiomyopathy assessed by cardiac magnetic resonance imaging and spectroscopy. Heart. 2014;100(Suppl 3):A73\u20134.","journal-title":"Heart"},{"issue":"7","key":"3117_CR46","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.echo.2025.03.011","volume":"38","author":"SF Nagueh","year":"2025","unstructured":"Nagueh SF, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography and for heart failure with preserved ejection fraction diagnosis: an update from the American Society of Echocardiography. J Am Soc Echocardiogr. 2025;38(7):537\u201369.","journal-title":"J Am Soc Echocardiogr"},{"issue":"4","key":"3117_CR47","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","volume":"29","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29(4):277\u2013314.","journal-title":"J Am Soc Echocardiogr"},{"key":"3117_CR48","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2147\/CIA.S399996","volume":"18","author":"J Wu","year":"2023","unstructured":"Wu J, et al. Echocardiography E\/A abnormality is associated with the development of primary left ventricle remodeling in middle-aged and elderly women: a longitudinal study. Clin Interv Aging. 2023;18:629\u201338.","journal-title":"Clin Interv Aging"},{"key":"3117_CR49","unstructured":"WBG. Low & middle income. 2024. Available from: https:\/\/data.worldbank.org\/income-level\/low-and-middle-income. Cited 20 August 2025."},{"issue":"6","key":"3117_CR50","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","volume":"30","author":"S Rubler","year":"1972","unstructured":"Rubler S, et al. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972;30(6):595\u2013602.","journal-title":"Am J Cardiol"},{"issue":"1","key":"3117_CR51","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, et al. Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.","journal-title":"Syst Rev"},{"key":"3117_CR52","unstructured":"Deeks JJ. Higgins, and D. Altman, Cochrane handbook for systematic reviews of interventions version 6.4. 2023."},{"issue":"5","key":"3117_CR53","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/EDE.0000000000001232","volume":"31","author":"L Lin","year":"2020","unstructured":"Lin L, Chu H. Meta-analysis of proportions using generalized linear mixed models. Epidemiology. 2020;31(5):713\u20137.","journal-title":"Epidemiology"},{"issue":"1","key":"3117_CR54","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/jrsm.1316","volume":"10","author":"D Langan","year":"2019","unstructured":"Langan D, et al. A comparison of heterogeneity variance estimators in simulated random-effects meta-analyses. Res Synth Methods. 2019;10(1):83\u201398.","journal-title":"Res Synth Methods"},{"issue":"1","key":"3117_CR55","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1164","volume":"7","author":"AA Veroniki","year":"2016","unstructured":"Veroniki AA, et al. Methods to estimate the between-study variance and its uncertainty in meta-analysis. Res Synth Methods. 2016;7(1):55\u201379.","journal-title":"Res Synth Methods"},{"issue":"1","key":"3117_CR56","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12874-015-0034-x","volume":"15","author":"E Kulinskaya","year":"2015","unstructured":"Kulinskaya E, Dollinger MB. An accurate test for homogeneity of odds ratios based on Cochran\u2019s Q-statistic. BMC Med Res Methodol. 2015;15(1):49.","journal-title":"BMC Med Res Methodol"},{"key":"3117_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2049-3258-72-39","volume":"72","author":"VN Nyaga","year":"2014","unstructured":"Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health. 2014;72:1\u201310.","journal-title":"Arch Public Health"},{"key":"3117_CR58","doi-asserted-by":"crossref","unstructured":"Nyaga VN, Arbyn M. Methods for meta-analysis and meta-regression of proportions: concepts and tutorial with Stata command metapreg. 2022.","DOI":"10.21203\/rs.3.rs-2142518\/v1"},{"issue":"1","key":"3117_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s13690-023-01215-y","volume":"82","author":"VN Nyaga","year":"2024","unstructured":"Nyaga VN, Arbyn M. Methods for meta-analysis and meta-regression of binomial data: concepts and tutorial with Stata command metapreg. Arch Public Health. 2024;82(1):14.","journal-title":"Arch Public Health"},{"key":"3117_CR60","unstructured":"StataCorp, Statistical software: release 18. 2023, College Station, TX: StataCorp LLC."},{"issue":"7109","key":"3117_CR61","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"issue":"9","key":"3117_CR62","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","volume":"65","author":"D Hoy","year":"2012","unstructured":"Hoy D, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65(9):934\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"3117_CR63","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004747","volume":"4","author":"M Werfalli","year":"2014","unstructured":"Werfalli M, et al. The prevalence of type 2 diabetes mellitus among older people in Africa: a systematic review study protocol. BMJ Open. 2014;4(6):e004747.","journal-title":"BMJ Open"},{"issue":"7650","key":"3117_CR64","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, et al. Grade: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136.","journal-title":"BMJ"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-026-03117-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-026-03117-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-026-03117-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:02:16Z","timestamp":1776085336000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13643-026-03117-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3117"],"URL":"https:\/\/doi.org\/10.1186\/s13643-026-03117-w","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patients or the public were not involved in the design, conduct, reporting, or\u00a0dissemination plans of this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient and public involvement"}},{"value":"Ethics approval or written consent is not required, as the review will be conducted using published data. The findings will be distributed through a peer-reviewed publication and conference presentation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"131"}}